Lung Cancer Clinical Trials in Huddersfield
3 recruitingHuddersfield, United Kingdom
Showing 1–3 of 3 trials
Recruiting
Phase 3
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Non-small Cell Lung Cancer (NSCLC)
AstraZeneca400 enrolled197 locationsNCT07291037
Recruiting
Phase 3
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Lung Cancer, Nonsmall Cell
Imperial College London1,750 enrolled37 locationsNCT05085028
Recruiting
Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study
Lung Cancer
Royal Marsden NHS Foundation Trust500 enrolled9 locationsNCT05432739